These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36652465)

  • 41. Catheter ablation of atrial fibrillation in patients with diabetes mellitus: a systematic review and meta-analysis.
    Anselmino M; Matta M; D'ascenzo F; Pappone C; Santinelli V; Bunch TJ; Neumann T; Schilling RJ; Hunter RJ; Noelker G; Fiala M; Frontera A; Thomas G; Katritsis D; Jais P; Weerasooriya R; Kalman JM; Gaita F
    Europace; 2015 Oct; 17(10):1518-25. PubMed ID: 26498716
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial.
    Morillo CA; Verma A; Connolly SJ; Kuck KH; Nair GM; Champagne J; Sterns LD; Beresh H; Healey JS; Natale A;
    JAMA; 2014 Feb; 311(7):692-700. PubMed ID: 24549549
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of sodium glucose cotransporter type 2 inhibitors on heart failure.
    Nassif ME; Kosiborod M
    Diabetes Obes Metab; 2019 Apr; 21 Suppl 2():19-23. PubMed ID: 31081589
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Catheter ablation of atrial fibrillation-A key role in heart failure therapy?
    Tose Costa Paiva B; Fischer TH; Brachmann J; Busch S
    Clin Cardiol; 2019 Mar; 42(3):400-405. PubMed ID: 30652321
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SGLT2 inhibitors and atrial fibrillation in type 2 diabetes: a systematic review with meta-analysis of 16 randomized controlled trials.
    Li WJ; Chen XQ; Xu LL; Li YQ; Luo BH
    Cardiovasc Diabetol; 2020 Aug; 19(1):130. PubMed ID: 32847602
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antidiabetic agents and risk of atrial fibrillation/flutter: A comparative critical analysis with a focus on differences between SGLT2 inhibitors and GLP-1 receptor agonists.
    Scheen AJ
    Diabetes Metab; 2022 Nov; 48(6):101390. PubMed ID: 36170946
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of Sodium-Glucose Cotransporter Inhibitors on Major Adverse Cardiovascular Events and Hospitalization for Heart Failure in Patients With Type 2 Diabetes Mellitus and Atrial Fibrillation.
    Kwon CH; Kim YJ; Kim MJ; Cha MJ; Cho MS; Nam GB; Choi KJ; Kim J
    Am J Cardiol; 2022 Sep; 178():35-42. PubMed ID: 35810007
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The CURE-AF trial: a prospective, multicenter trial of irrigated radiofrequency ablation for the treatment of persistent atrial fibrillation during concomitant cardiac surgery.
    Damiano RJ; Badhwar V; Acker MA; Veeragandham RS; Kress DC; Robertson JO; Sundt TM
    Heart Rhythm; 2014 Jan; 11(1):39-45. PubMed ID: 24184028
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Uninterrupted administration of edoxaban vs vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation: Rationale and design of the ELIMINATE-AF study.
    Hohnloser SH; Camm J; Cappato R; Diener HC; Heidbuchel H; Lanz HJ; Mont L; Morillo CA; Smolnik R; Yin OQP; Kautzner J
    Clin Cardiol; 2018 Apr; 41(4):440-449. PubMed ID: 29663464
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cryoballoon Ablation for the Treatment of Atrial Fibrillation in Patients With Concomitant Heart Failure and Either Reduced or Preserved Left Ventricular Ejection Fraction: Results From the Cryo AF Global Registry.
    Rordorf R; Scazzuso F; Chun KRJ; Khelae SK; Kueffer FJ; Braegelmann KM; Okumura K; Al-Kandari F; On YK; Földesi C;
    J Am Heart Assoc; 2021 Dec; 10(24):e021323. PubMed ID: 34889108
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of sodium glucose co-transporter inhibitors in heart failure prevention.
    Garla V; Subauste A; Butler J; Lien LF
    J Diabetes Complications; 2021 Mar; 35(3):107811. PubMed ID: 33280983
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF).
    Lee MMY; Brooksbank KJM; Wetherall K; Mangion K; Roditi G; Campbell RT; Berry C; Chong V; Coyle L; Docherty KF; Dreisbach JG; Labinjoh C; Lang NN; Lennie V; McConnachie A; Murphy CL; Petrie CJ; Petrie JR; Speirits IA; Sourbron S; Welsh P; Woodward R; Radjenovic A; Mark PB; McMurray JJV; Jhund PS; Petrie MC; Sattar N
    Circulation; 2021 Feb; 143(6):516-525. PubMed ID: 33186500
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of DrOnedarone on atrial fibrosis progression and atrial fibrillation recurrence postablation: Design of the EDORA randomized clinical trial.
    Marrouche NF; Dagher L; Wazni O; Akoum N; Mansour M; El Hajjar AH; Bhatnagar A; Hua H;
    J Cardiovasc Electrophysiol; 2021 Dec; 32(12):3203-3210. PubMed ID: 34664772
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rationale for the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial.
    Roy D
    Card Electrophysiol Rev; 2003 Sep; 7(3):208-10. PubMed ID: 14739714
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.
    Rodgers M; McKenna C; Palmer S; Chambers D; Van Hout S; Golder S; Pepper C; Todd D; Woolacott N
    Health Technol Assess; 2008 Nov; 12(34):iii-iv, xi-xiii, 1-198. PubMed ID: 19036232
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pulmonary Vein Isolation Alone Versus Additional Linear Ablation in Patients With Persistent Atrial Fibrillation Converted to Paroxysmal Type With Antiarrhythmic Drug Therapy: A Multicenter, Prospective, Randomized Study.
    Yu HT; Shim J; Park J; Kim IS; Kim TH; Uhm JS; Joung B; Lee MH; Kim YH; Pak HN
    Circ Arrhythm Electrophysiol; 2017 Jun; 10(6):. PubMed ID: 28611206
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sodium-glucose cotransporter 2 inhibitor may not prevent atrial fibrillation in patients with heart failure: a systematic review.
    Ouyang X; Wang J; Chen Q; Peng L; Li S; Tang X
    Cardiovasc Diabetol; 2023 May; 22(1):124. PubMed ID: 37226247
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of SGLT-2 inhibitors as an add-on therapy to metformin on P wave indices and atrial electromechanics in type 2 diabetes mellitus patients.
    Ziyrek M; Dönmez E; Özcan S; Duran M; Tezcan H; İnce O; Özdemir E; Sahin I; Okuyan E
    Pacing Clin Electrophysiol; 2023 Jul; 46(7):803-810. PubMed ID: 37120828
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study).
    Mont L; Bisbal F; Hernández-Madrid A; Pérez-Castellano N; Viñolas X; Arenal A; Arribas F; Fernández-Lozano I; Bodegas A; Cobos A; Matía R; Pérez-Villacastín J; Guerra JM; Ávila P; López-Gil M; Castro V; Arana JI; Brugada J;
    Eur Heart J; 2014 Feb; 35(8):501-7. PubMed ID: 24135832
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A randomized clinical trial of early invasive intervention for atrial fibrillation (EARLY-AF) - methods and rationale.
    Andrade JG; Champagne J; Deyell MW; Essebag V; Lauck S; Morillo C; Sapp J; Skanes A; Theoret-Patrick P; Wells GA; Verma A;
    Am Heart J; 2018 Dec; 206():94-104. PubMed ID: 30342299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.